Asciminib: High Responses in Second-Line Chronic-Phase CML ...Middle East

Medscape - News
Asciminib: High Responses in Second-Line Chronic-Phase CML
In interim analysis of phase 2 ASC2ESCALATE trial, patients with chronic-phase chronic myeloid leukemia who fail to respond to first-line therapies show major molecular responses to asciminib. Medscape Medical News

Hence then, the article about asciminib high responses in second line chronic phase cml was published today ( ) and is available on Medscape ( Middle East ) The editorial team at PressBee has edited and verified it, and it may have been modified, fully republished, or quoted. You can read and follow the updates of this news or article from its original source.

Read More Details
Finally We wish PressBee provided you with enough information of ( Asciminib: High Responses in Second-Line Chronic-Phase CML )

Apple Storegoogle play

Last updated :

Also on site :